✦ LIBER ✦

Pharmacokinetics of peginterferon ALFA-2A (40KD, PEGASYS) compared to peginterferon ALFA-2B (12KD, PEGINTRON) in naive patients with chronic hepatitis C (CHC)

✍ Scribed by R. Bruno; P. Sacchi; V. Ciappina; E. Maffezzini; S.F.A. Patruno; C. Zocchetti; G. Filice

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN9 A COST UTILITY ANALYSIS OF PEGINTER

✍ NR Latimer; GJ Lewis 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Pharmacodynamics of peginterferon alfa-2

✍ R. BRUNO; P. SACCHI; C. SCAGNOLARI; F. TORRIANI; L. MAIOCCHI; S. PATRUNO; F. BEL 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

454 PREDICTIVE FACTORS OF THROMBOCYTOPEN

✍ S. Mauss; A. Schober; T. Lutz; G. Moog; M. Schuchmann; R. Heyne; C. John; W. Sch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Predictors of virologic relapse in patie

✍ V. Balan; S. Zeuzem; H. Sette; M. Fried; D. Jensen; G. Pastore; P. Marcellin; F. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Week 12 EVR predicts EOT in CHC genotype

✍ O. Shobokshi; F.E. Serebour; L. Skakni; N. Al-Jasser; A.O. Tantawi; A. Sabah; T. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

A randomised trial to compare the pharma

✍ Marcelo Silva; Jorge Poo; Frank Wagner; Mary Jackson; David Cutler; Michael Grac 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 814 KB